Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1982 1
1985 1
1988 1
1989 1
1990 1
1991 1
1993 1
1995 2
1997 1
2002 1
2003 2
2005 1
2009 1
2016 1
2017 1
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Managing player load in professional rugby union: a review of current knowledge and practices.
Quarrie KL, Raftery M, Blackie J, Cook CJ, Fuller CW, Gabbett TJ, Gray AJ, Gill N, Hennessy L, Kemp S, Lambert M, Nichol R, Mellalieu SD, Piscione J, Stadelmann J, Tucker R. Quarrie KL, et al. Among authors: blackie j. Br J Sports Med. 2017 Mar;51(5):421-427. doi: 10.1136/bjsports-2016-096191. Epub 2016 Aug 9. Br J Sports Med. 2017. PMID: 27506436 Review.
Subcultural mental handicap.
Blackie J, Forrest A, Witcher G. Blackie J, et al. Br J Psychiatry. 1975 Dec;127:535-9. doi: 10.1192/bjp.127.6.535. Br J Psychiatry. 1975. PMID: 1201444
Hazardous drinking in elite New Zealand sportspeople.
O'Brien KS, Blackie JM, Hunter JA. O'Brien KS, et al. Among authors: blackie jm. Alcohol Alcohol. 2005 May-Jun;40(3):239-41. doi: 10.1093/alcalc/agh145. Epub 2005 Mar 29. Alcohol Alcohol. 2005. PMID: 15797880
Anti-melanin antibodies are increased in sera in Parkinson's disease.
Double KL, Rowe DB, Carew-Jones FM, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Riederer P, Gerlach M, Halliday GM. Double KL, et al. Among authors: blackie j. Exp Neurol. 2009 Jun;217(2):297-301. doi: 10.1016/j.expneurol.2009.03.002. Epub 2009 Mar 13. Exp Neurol. 2009. PMID: 19289120
Botulinum toxin treatment in spasmodic torticollis.
Blackie JD, Lees AJ. Blackie JD, et al. J Neurol Neurosurg Psychiatry. 1990 Aug;53(8):640-3. doi: 10.1136/jnnp.53.8.640. J Neurol Neurosurg Psychiatry. 1990. PMID: 2213040 Free PMC article. Clinical Trial.
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2.
Blackie JA, Bloomer JC, Brown MJ, Cheng HY, Hammond B, Hickey DM, Ife RJ, Leach CA, Lewis VA, Macphee CH, Milliner KJ, Moores KE, Pinto IL, Smith SA, Stansfield IG, Stanway SJ, Taylor MA, Theobald CJ. Blackie JA, et al. Bioorg Med Chem Lett. 2003 Mar 24;13(6):1067-70. doi: 10.1016/s0960-894x(03)00058-1. Bioorg Med Chem Lett. 2003. PMID: 12643913
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in man.
Blackie JA, Bloomer JC, Brown MJ, Cheng HY, Elliott RL, Hammond B, Hickey DM, Ife RJ, Leach CA, Lewis VA, Macphee CH, Milliner KJ, Moores KE, Pinto IL, Smith SA, Stansfield IG, Stanway SJ, Taylor MA, Theobald CJ, Whittaker CM. Blackie JA, et al. Bioorg Med Chem Lett. 2002 Sep 16;12(18):2603-6. doi: 10.1016/s0960-894x(02)00473-0. Bioorg Med Chem Lett. 2002. PMID: 12182870
18 results